A Computational Study of the Protein-ligand Interactions in CDK2 Inhibitors: Using Quantum Mechanics/molecular Mechanics Interaction Energy As a Predictor of the Biological Activity

Overview

Journal Biophys J

Publisher Cell Press

Specialty Biophysics

Date 2006 Nov 7

PMID 17085505

Citations 7

Authors

Jans H Alzate-Morales

Renato Contreras

Alejandro Soriano

Inaki Tunon

Estanislao Silla

Affiliations

Soon will be listed here.

Abstract

We report a combined quantum mechanics/molecular mechanics (QM/MM) study to determine the protein-ligand interaction energy between CDK2 (cyclin-dependent kinase 2) and five inhibitors with the N(2)-substituted 6-cyclohexyl-methoxy-purine scaffold. The computational results in this work show that the QM/MM interaction energy is strongly correlated to the biological activity and can be used as a predictor, at least within a family of substrates. A detailed analysis of the protein-ligand structures obtained from molecular dynamics simulations shows specific interactions within the active site that, in some cases, have not been reported before to our knowledge. The computed interaction energy gauges the strength of protein-ligand interactions. Finally, energy decomposition and multiple regression analyses were performed to check the contribution of the electrostatic and van der Waals energies to the total interaction energy and to show the capabilities of the computational model to identify new potent inhibitors.

Citing Articles

Statistical Improvement of rGILCC 1 and rPOXA 1B Laccases Activity Assay Conditions Supported by Molecular Dynamics.

Mora-Gamboa M, Ferrucho-Calle M, Ardila-Leal L, Rojas-Ojeda L, Galindo J, Poutou-Pinales R Molecules. 2023; 28(21).

PMID: 37959683 PMC: 10648076. DOI: 10.3390/molecules28217263.

Intermolecular Interactions of Nucleoside Antibiotic Tunicamycin with On-Target MraY-TUN and Off-Target DPAGT1-TUN in the Active Sites Delineated by Quantum Mechanics/Molecular Mechanics Calculations.

Astani E, Zadeh S, Hsu N, Lin K, Sardari S, Li T ACS Omega. 2022; 7(37):32970-32987.

PMID: 36157785 PMC: 9494639. DOI: 10.1021/acsomega.2c02213.

Bioactive focus in conformational ensembles: a pluralistic approach.

Habgood M J Comput Aided Mol Des. 2017; 31(12):1073-1083.

PMID: 29189937 DOI: 10.1007/s10822-017-0089-3.

Correlation between biological activity and binding energy in systems of integrin with cyclic RGD-containing binders: a QM/MM molecular dynamics study.

Xiang M, Lin Y, He G, Chen L, Yang M, Yang S J Mol Model. 2012; 18(11):4917-27.

PMID: 22736220 DOI: 10.1007/s00894-012-1487-z.

Quantum mechanics study of the hydroxyethylamines-BACE-1 active site interaction energies.

Gueto-Tettay C, Drosos J, Vivas-Reyes R J Comput Aided Mol Des. 2011; 25(6):583-97.

PMID: 21691813 DOI: 10.1007/s10822-011-9443-z.

References

Hanks S, Hunter T . Protein kinases 6. The eukaryotic protein kinase superfamily: kinase (catalytic) domain structure and classification. FASEB J. 1995; 9(8):576-96. View

Arris C, Boyle F, Calvert A, Curtin N, Endicott J, Garman E . Identification of novel purine and pyrimidine cyclin-dependent kinase inhibitors with distinct molecular interactions and tumor cell growth inhibition profiles. J Med Chem. 2000; 43(15):2797-804. DOI: 10.1021/jm990628o. View

Gohlke H, Klebe G . Statistical potentials and scoring functions applied to protein-ligand binding. Curr Opin Struct Biol. 2001; 11(2):231-5. DOI: 10.1016/s0959-440x(00)00195-0. View

Gao J, Truhlar D . Quantum mechanical methods for enzyme kinetics. Annu Rev Phys Chem. 2002; 53:467-505. DOI: 10.1146/annurev.physchem.53.091301.150114. View

Gao J, Xia X . A priori evaluation of aqueous polarization effects through Monte Carlo QM-MM simulations. Science. 1992; 258(5082):631-5. DOI: 10.1126/science.1411573. View

Grater F, Schwarzl S, Dejaegere A, Fischer S, Smith J . Protein/ligand binding free energies calculated with quantum mechanics/molecular mechanics. J Phys Chem B. 2006; 109(20):10474-83. DOI: 10.1021/jp044185y. View

Sims P, Wong C, McCammon J . A computational model of binding thermodynamics: the design of cyclin-dependent kinase 2 inhibitors. J Med Chem. 2003; 46(15):3314-25. DOI: 10.1021/jm0205043. View

Teague S . Implications of protein flexibility for drug discovery. Nat Rev Drug Discov. 2003; 2(7):527-41. DOI: 10.1038/nrd1129. View

Losiewicz M, Carlson B, Kaur G, Sausville E, Worland P . Potent inhibition of CDC2 kinase activity by the flavonoid L86-8275. Biochem Biophys Res Commun. 1994; 201(2):589-95. DOI: 10.1006/bbrc.1994.1742. View

10.

Gray N, Detivaud L, Doerig C, Meijer L . ATP-site directed inhibitors of cyclin-dependent kinases. Curr Med Chem. 1999; 6(9):859-75. View

11.

Marti S, Moliner V, Tunon I . Improving the QM/MM Description of Chemical Processes: A Dual Level Strategy To Explore the Potential Energy Surface in Very Large Systems. J Chem Theory Comput. 2015; 1(5):1008-16. DOI: 10.1021/ct0501396. View

12.

BRANDSEN J, Jones H, MORGAN D, Meijer L, Vesely J, Kim S . Multiple modes of ligand recognition: crystal structures of cyclin-dependent protein kinase 2 in complex with ATP and two inhibitors, olomoucine and isopentenyladenine. Proteins. 1995; 22(4):378-91. DOI: 10.1002/prot.340220408. View

13.

Hardcastle I, Arris C, Bentley J, Boyle F, Chen Y, Curtin N . N2-substituted O6-cyclohexylmethylguanine derivatives: potent inhibitors of cyclin-dependent kinases 1 and 2. J Med Chem. 2004; 47(15):3710-22. DOI: 10.1021/jm0311442. View

14.

Gray N, Wodicka L, Thunnissen A, Norman T, Kwon S, Espinoza F . Exploiting chemical libraries, structure, and genomics in the search for kinase inhibitors. Science. 1998; 281(5376):533-8. DOI: 10.1126/science.281.5376.533. View

15.

CARLSON H, McCammon J . Accommodating protein flexibility in computational drug design. Mol Pharmacol. 2000; 57(2):213-8. View

16.

Sims P, Wong C, McCammon J . Charge optimization of the interface between protein kinases and their ligands. J Comput Chem. 2004; 25(11):1416-29. DOI: 10.1002/jcc.20067. View

17.

Wong C, Hunenberger P, Akamine P, Narayana N, DILLER T, McCammon J . Computational analysis of PKA-balanol interactions. J Med Chem. 2001; 44(10):1530-9. DOI: 10.1021/jm000443d. View

18.

Senderowicz A, Sausville E . Preclinical and clinical development of cyclin-dependent kinase modulators. J Natl Cancer Inst. 2000; 92(5):376-87. DOI: 10.1093/jnci/92.5.376. View

19.

Hensen C, Hermann J, Nam K, Ma S, Gao J, Holtje H . A combined QM/MM approach to protein--ligand interactions: polarization effects of the HIV-1 protease on selected high affinity inhibitors. J Med Chem. 2004; 47(27):6673-80. DOI: 10.1021/jm0497343. View

20.

Schaftenaar G, Noordik J . Molden: a pre- and post-processing program for molecular and electronic structures. J Comput Aided Mol Des. 2000; 14(2):123-34. DOI: 10.1023/a:1008193805436. View